Vendis Capital has sealed a €290m sale of Belgian teeth, mouth and skincare products business Sylphar to EQT portfolio business Karo Pharma.
The post Vendis Capital seals €290m Sylphar sale to EQT’s Karo Pharma first appeared on AltAssets Private Equity News.